Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)


Journal article


Sven Borchmann, Horst Müller, Heinz Haverkamp, Christian Baues, Jana Marková, Andreas Hüttmann, Axel Glunz, Michael Fuchs, Peter Borchmann, Andreas Engert
Leukemia, vol. 33(2), 2019 Jan 1, pp. 439-446

Cite

APA
Borchmann, S., Müller, H., Haverkamp, H., Baues, C., Marková, J., Hüttmann, A., … Engert, A. (2019). Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG). Leukemia, 33(2), 439–446.

Chicago/Turabian
Borchmann, Sven, Horst Müller, Heinz Haverkamp, Christian Baues, Jana Marková, Andreas Hüttmann, Axel Glunz, Michael Fuchs, Peter Borchmann, and Andreas Engert. “Symptomatic Osteonecrosis as a Treatment Complication in Hodgkin Lymphoma: an Analysis of the German Hodgkin Study Group (GHSG).” Leukemia 33, no. 2 (January 1, 2019): 439–446.

MLA
Borchmann, Sven, et al. “Symptomatic Osteonecrosis as a Treatment Complication in Hodgkin Lymphoma: an Analysis of the German Hodgkin Study Group (GHSG).” Leukemia, vol. 33, no. 2, Jan. 2019, pp. 439–46.